Abstract: A massage chair for bathing includes a chair seat, a seat back, and a massage device. The massage device is positioned on at least one of the chair seat and the seat back, where the seat back and the chair seat are connected using a locking unit.

Abstract: This disclosure provides multispecific and multivalent antigen binding proteins. In one aspect, the disclosure provides a multispecific antigen binding protein, comprising a first antigen binding site comprising a first VHH that specifically binds to a first epitope; and a second antigen binding site that specifically binds to a second epitope.

Abstract: Embodiments provide a scheme for non-parametric PV-level modeling and an optimal read threshold voltage estimation in a memory system. A controller is configured to: generate multiple optimal read threshold voltages corresponding to multiple sets of two cumulative distribution function (CDF) values, respectively; perform read operations on the cells using a plurality of read threshold voltages; generate cumulative mass function (CMF) samples based on the results of the read operations; receive first and second CDF values, selected from among a plurality of CDF values, each CDF value corresponding to each CMF sample; and estimate an optimal read threshold voltage corresponding to the first and second CDF values, among the multiple optimal read threshold voltages.

Abstract: Embodiments provide a scheme for non-parametric PV-level modeling and an optimal read threshold voltage estimation in a memory system. A controller is configured to: generate multiple optimal read threshold voltages corresponding to multiple sets of two cumulative distribution function (CDF) values, respectively; perform read operations on the cells using a plurality of read threshold voltages; generate cumulative mass function (CMF) samples based on the results of the read operations; receive first and second CDF values, selected from among a plurality of CDF values, each CDF value corresponding to each CMF sample; and estimate an optimal read threshold voltage corresponding to the first and second CDF values, among the multiple optimal read threshold voltages.

Abstract: Disclosed are devices, systems and methods for providing hardware implementations of a quasi-cyclic syndrome decoder. An example method of reducing the complexity of a decoder includes receiving a noisy codeword that is a based on a transmitted codeword generated from a quasi-cyclic linear code; computing a plurality of syndromes based on the noisy codeword; selecting a first syndrome from the plurality of syndromes; generating a memory cell address as a function of the first syndrome; reading, based on the memory cell address, a coset leader corresponding to the first syndrome; and determining, based on the noisy codeword and the coset leader, a candidate version of the transmitted codeword.

Abstract: Disclosed are devices, systems and methods for reducing the latency of a quasi-cyclic linear code decoder. An example method includes receiving a noisy codeword, the codeword having been generated from a quasi-cyclic linear code and provided to a communication channel prior to reception by the decoder; computing a syndrome based on the noisy codeword; generating a plurality of memory cell addresses, a first memory cell address being a function of the syndrome and subsequent memory cell addresses being within a predetermined address range of the function of the syndrome; reading, in a parallel manner to reduce the latency of the decoder, a plurality of error patterns from the plurality of memory cell addresses and computing a checksum for each of the plurality of error patterns; and determining, based on the checksum for each of the plurality of error patterns, a candidate version of the transmitted codeword.

Abstract: Disclosed are devices, systems and methods for reducing the latency of a quasi-cyclic linear code decoder. An example method includes receiving a noisy codeword, the codeword having been generated from a quasi-cyclic linear code and provided to a communication channel prior to reception by the decoder; computing a syndrome based on the noisy codeword; generating a plurality of memory cell addresses, a first memory cell address being a function of the syndrome and subsequent memory cell addresses being within a predetermined address range of the function of the syndrome; reading, in a parallel manner to reduce the latency of the decoder, a plurality of error patterns from the plurality of memory cell addresses and computing a checksum for each of the plurality of error patterns; and determining, based on the checksum for each of the plurality of error patterns, a candidate version of the transmitted codeword.

Abstract: Techniques related to improving a performance related to at least data reads from a memory are described. In an example, a computer system hosts a regression model that includes a neural network. The neural network is trained based on training data that is measured under different combinations of operational conditions and storage conditions. In operation, actual operational and storage conditions associated with the memory are input to the regression model. The neural network outputs a voltage read threshold based on these actual conditions. The computer system uses the voltage read threshold to read data stored in the memory.

Abstract: Techniques related to improving a performance related to at least data reads from a memory are described. In an example, a computer system hosts a regression model that includes a neural network. The neural network is trained based on training data that is measured under different combinations of operational conditions and storage conditions. In operation, actual operational and storage conditions associated with the memory are input to the regression model. The neural network outputs a voltage read threshold based on these actual conditions. The computer system uses the voltage read threshold to read data stored in the memory.

Abstract: A magnetic installation base provided by the present invention comprises: a base applicable to be connected with an acceleration sensor; and a magnet set installed on the base and having an adsorption surface formed at an end far away from the base. The magnet set comprises several magnets, and the ends of adjacent magnets forming the adsorption surface have opposite polarities. During use, the magnetic installation base is adsorbed onto the surface of a to-be-tested object, therefore, the appearance of the to-be-tested object does not need to be destroyed, moreover, since the ends of adjacent magnets forming the adsorption surface have opposite polarities, the adsorption surface is ensured to have sufficient magnetic lines, and the adsorption capacity is larger.

Abstract: Specific binding members that bind the ED-A isoform of fibronectin for use in methods of treatment, diagnosis, detection and/or imaging of inflammatory bowel disease (IBD), and/or for use in delivery to the IBD tissue of a molecule conjugated to the specific binding member. The specific binding member may, for example, be conjugated to an immunosupressive or anti-inflammatory molecule, such as interleukin-10.

Abstract: Specific binding members that bind the ED-A isoform of fibronectin for use in methods of treatment, diagnosis, detection and/or imaging of inflammatory bowel disease (IBD), and/or for use in delivery to the IBD tissue of a molecule conjugated to the specific binding member. The specific binding member may, for example, be conjugated to an immunosupressive or anti-inflammatory molecule, such as interleukin-10.

Abstract: Specific binding members that bind the ED-A isoform of fibronectin for use in methods of treatment, diagnosis, detection and/or imaging of inflammatory bowel disease (IBD), and/or for use in delivery to the IBD tissue of a molecule conjugated to the specific binding member. The specific binding member may, for example, be conjugated to an immunosupressive or anti-inflammatory molecule, such as interleukin-10.

Abstract: Specific binding members that bind the ED-A isoform of fibronectin for use in methods of treatment, diagnosis, detection and/or imaging of inflammatory bowel disease (IBD), and/or for use in delivery to the IBD tissue of a molecule conjugated to the specific binding member. The specific binding member may, for example, be conjugated to an immunosupressive or anti-inflammatory molecule, such as interleukin-10.

Abstract: A method for data sequence detection includes generating a first sample stream, equalizing the first sample stream to generate a first equalized sample stream, and buffering the first equalized sample stream. The first sample stream is interpolated to generate a second sample stream. The second sample stream is equalized to generate a second equalized sample stream. In a first processing path, the samples of the buffered first equalized sample stream are filtered using a first noise predictive filter bank to generate a first set of noise sample streams. In a second parallel processing path, the samples of the buffered first equalized sample stream are interpolated using a second interpolation filter to generate an interpolated sample stream and the interpolated sample stream is filtered to generate a second set of noise sample streams. The first equalized sample stream and the second equalized sample stream are processed to generate adapted filter coefficients for the second interpolation filter.

Abstract: A videoconference system and a management method thereof are provided. The videoconference system includes: terminals; multipoint control units (MCUs), as the superior level for the terminals, for controlling the corresponding terminals; conference management systems, as the superior level for the MCUs, for performing dispatching and control for the local conference site; and conference coordination systems, as the superior level for the conference management systems, for coordinating corresponding conference management systems and neighboring conference coordination systems to perform dispatching and control for the entire conference.

Abstract: Stabilized radiopharmaceutical formulations are disclosed. Methods of making and using stabilized radiopharmaceutical formulations are also disclosed. The invention relates to stabilizers that improve the radiostability of radiotherapeutic and radiodiagnostic compounds and formulations containing them. In particular, it relates to stabilizers useful in the preparation and stabilization of targeted radiodiagnostic and radiotherapeutic compounds, and, in a preferred embodiment, to the preparation and stabilization of radiodiagnostic and radiotherapeutic compounds that are targeted to the Gastrin Releasing Peptide Receptor (GRP-Receptor).

Abstract: This invention relates to novel diaryl ureas, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for treating hyper-proliferative and angiogenesis disorders, as a sole agent or in combination with cytotoxic therapies.

Abstract: Stabilized radiopharmaceutical formulations are disclosed. Methods of making and using stabilized radiopharmaceutical formulations are also disclosed. The invention relates to stabilizers that improve the radiostability of radiotherapeutic and radiodiagnostic compounds, and formulations containing them. In particular, it relates to stabilizers useful in the preparation and stabilization of targeted radiodiagnostic and radiotherapeutic compounds, and, in a preferred embodiment, to the preparation and stabilization of radiodiagnostic and radiotherapeutic compounds that are targeted to the Gastrin Releasing Peptide Receptor (GRP-Receptor).

Abstract: Provided is a pharmaceutical composition comprising radioiodinated N-(2-(diethylamino)ethyl)-4-(4-fluorobenzamido)-5-iodo-2-methoxybenzamide of Formula I. The pharmaceutical composition provides a stable formulation for both storing and administering to patients having melanoma. Also provided is a novel method of iodinating the precursor compound.